Exactly KC, this is exciting, the real Mccoy....just hope this...

Exactly KC, this is exciting, the real Mccoy....just hope this definitive agreement is announced soon!


Prior to the signing of a definitive agreement, the parties will finalise a development plan for the TPM®/Oxymorphone patch in Japan, and may request a formal consultation with the Japanese regulatory agency (Pharmaceutical and Medical Devices Agency). It is anticipated that Phosphagenics would continue to support some development, with Terumo funding the development and commercial activities required for the Japanese market. Negotiations related to the financial terms in the agreement have already begun, and include upfront, development and sales milestones, as well as single to double digit royalties on net sales in Japan.